Gilead Foundation: Grants for Diseases

OVERVIEW: Gilead’s grantmaking revolves around HIV/AIDS, liver disease, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.

IP TAKE: Grantseekers should be aware that Gilead’s review process can take up to 12 weeks, so this is not a funder for those looking for fast funding. 

PROFILE: The Gilead Foundation is the philanthropic arm of the biopharmaceutical Gilead Sciences. The overall focus of Gilead’s grantmaking is projects that improve the health of local communities within its therapeutic areas of interest. The foundation “works hard to foster deep and enduring relationships with patient advocates, nonprofits and healthcare professionals around the world.” Its overall grantmaking priorities are providing access, reducing disparities, advancing medical education, and supporting local communities.

Gilead’s North American disease grantmaking centers on organizations in the “core therapeutic areas.” Its overall HIV/AIDS funding supports “organizations working to help individuals learn their status and get the care they need.” HIV Cure funding has the goals of “discovering transformative and life-saving medicines,” “developing simplified treatment regimens that increase efficacy,” and “expanding access to treatment for those who need it most.” The foundation also has an HIV Prevention program that supports “efforts of community-based organizations, public health entities and similar nonprofit organizations to educate their constituents about comprehensive HIV prevention.”

Gilead’s Liver Disease grants works to expand access to testing and care for Hepatitis C among “drug users, minorities and other at-risk groups.” Hematology and Oncology grants generally work to “improve health literacy, enabling individuals affected by cancer to make informed health decisions.” Finally Gilead’s Inflammatory and Respiratory Diseases funding aims to expand access to care and “educate healthcare providers on identification, screening, and diagnosis” for diseases such as cystic fibrosis and influenza.”

Gilead’s giving in Latin America and Australia resembles its North American grantmaking, while grantmaking in Africa and Asia prioritizes HIV/AIDS and viral hepatitis.

Gilead does not put a limit on its grant amounts, but grants tend to range from $50,000 to $250,000.

Gilead accepts grant applications year-round through its website. The foundation recommends that potential grantees submit applications at least six weeks prior to the start of their projects.  

PEOPLE:

Search for staff contact info and bios in PeopleFinder (paid subscribers only).

LINKS: